No role for melanoma treatment in the association between melanoma and amyotrophic lateral sclerosis or Parkinson's disease
- PMID: 20962539
- PMCID: PMC2974840
- DOI: 10.1159/000321177
No role for melanoma treatment in the association between melanoma and amyotrophic lateral sclerosis or Parkinson's disease
Comment on
-
Mortality due to amyotrophic lateral sclerosis and Parkinson's disease among melanoma patients.Neuroepidemiology. 2007;28(1):16-20. doi: 10.1159/000097851. Neuroepidemiology. 2007. PMID: 17164565
References
-
- Baade PD, Fritschi L, Freedman DM. Mortality due to amyotrophic lateral sclerosis and Parkinson's disease among melanoma patients. Neuroepidemiology. 2007;28:16–20. - PubMed
-
- Freedman DM, Travis LB, Gridley G, Kuncl RW. Amyotrophic lateral sclerosis mortality in 1.9 million US cancer survivors. Neuroepidemiology. 2005;25:176–180. - PubMed
-
- Coory M, Smithers M, Aitken J, Baade P, Ring I. Urban-rural differences in survival from cutaneous melanoma in Queensland. Aust NZ J Public Health. 2006;30:71–74. - PubMed
-
- Schiff D, Wen PY, van den Bent MJ. Neurological adverse effects caused by cytotoxic and targeted therapies. Nat Rev Clin Oncol. 2009;6:596–603. - PubMed
-
- Sul JK, Deangelis LM. Neurologic complications of cancer chemotherapy. Semin Oncol. 2006;33:324–332. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
